Skip to content
Recall Observatory FDA recall evidence

Drug product

Clozapine Orally Disintegrating Tablets, 12.5 mg, 100-count bottles, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-5416-01 Yellow, round, flat-faced, beveled-edge, unscored tablet. Debossed with 13 on one side and plain on the other side.

D-0001-2019

September 21, 2018

Class II

Product summary

Firm
Teva Pharmaceuticals USA
Event
Event 81068
Status
Terminated
Classification
Class II
Quantity
313 bottles
Official record key
drug-enforcement:D-0001-2019

Official wording

Reason: Failed Disintegration Specifications: Out-of-specification disintegration test result obtained during routine stability testing.

Code information: Lot #: 34034024B, Exp 02/20

Distribution pattern: Distributed nationwide in the USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Out-of-specification